sl-325
·Code: SL-325
sl-325: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Shattuck Labs, Inc. (STTK) | Phase 1 |
Clinical Trials (1)
A Randomized, Double-Blind, Placebo-Controlled Single-Ascending Dose and Multiple-Ascending Dose Phase 1 Study of SL-325 in Healthy Volunteers
Frequently asked questions
Who is developing sl-325?
sl-325 is being developed by Shattuck Labs, Inc..
How many clinical trials involve sl-325?
BioSniper tracks 1 clinical trial involving sl-325.
Get deeper analysis on sl-325
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis